论文部分内容阅读
目的观察热毒宁治疗癌性发热的临床疗效。方法将90例癌性发热病人随机分为治疗组和对照组,每组45例。治疗组患者采用热毒宁静脉点滴,对照组患者采用口服消炎痛,均治疗7天,观察两组患者降温效果及不良发应。结果治疗组患者总有效率为86.6%,对照组为66.6%,两组比较差异有统计学意义(P<0.05)。不良反应比较,治疗组明显低于对照组。结论热毒宁治疗癌性发热疗效确切,安全性高。
Objective To observe the clinical efficacy of Renduining in the treatment of cancerous fever. Methods Ninety patients with cancerous fever were randomly divided into treatment group and control group, with 45 cases in each group. The patients in the treatment group were treated with intravenous injection of Hyperthermogram, and the patients in the control group were treated with oral indomethacin for 7 days. The cooling effect and adverse reactions in both groups were observed. Results The total effective rate was 86.6% in the treatment group and 66.6% in the control group, with significant difference between the two groups (P <0.05). Adverse reactions, the treatment group was significantly lower than the control group. Conclusion Rendunning treatment of cancerous fever is effective and safe.